Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Friis

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Acta Psychiatrica Scandinavica|January 21, 2010
A 2-year follow-up of involuntary admission's influence upon adherence and outcome in first-episode psychosisS Opjordsmoen, S Friis, I Melle, et al.
Psychological Medicine|December 12, 2007
Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorderP A Ringen, T V Lagerberg, A B Birkenaes, et al.
The American Journal of Psychiatry|November 3, 2001
Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatmentT K Larsen, T H McGlashan, J O Johannessen, et al.
Cancer Genetics and Cytogenetics|September 30, 2010
Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AMLBirgitte S Preiss, Olav J Bergmann, Olav J Bergman, et al.
Schizophrenia Research|August 2, 2001
Early detection strategies for untreated first-episode psychosisJ O Johannessen, T H McGlashan, T K Larsen, et al.
Psychological Medicine|October 15, 2010
Early detection of psychosis: positive effects on 5-year outcomeT K Larsen, I Melle, B Auestad, et al.
Acta Psychiatrica Scandinavica|December 18, 2007
Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional studyP A Ringen, I Melle, A B Birkenaes, et al.
Oncogene|January 29, 2014
Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesisK U Sales, S Friis, J E Konkel, et al.
Acta Psychiatrica Scandinavica|August 21, 2010
Early identification of non-remission in first-episode psychosis in a two-year outcome studyErik Simonsen, S Friis, S Opjordsmoen, et al.
European Journal of Gastroenterology & Hepatology|April 16, 2002
Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1)Jeroen D van Bergeijk, J H Paul Wilson, Ole Haage Nielsen, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Acta Psychiatrica Scandinavica|January 21, 2010
A 2-year follow-up of involuntary admission's influence upon adherence and outcome in first-episode psychosisS Opjordsmoen, S Friis, I Melle, et al.
Psychological Medicine|December 12, 2007
Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorderP A Ringen, T V Lagerberg, A B Birkenaes, et al.
The American Journal of Psychiatry|November 3, 2001
Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatmentT K Larsen, T H McGlashan, J O Johannessen, et al.
Cancer Genetics and Cytogenetics|September 30, 2010
Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AMLBirgitte S Preiss, Olav J Bergmann, Olav J Bergman, et al.
Schizophrenia Research|August 2, 2001
Early detection strategies for untreated first-episode psychosisJ O Johannessen, T H McGlashan, T K Larsen, et al.
Psychological Medicine|October 15, 2010
Early detection of psychosis: positive effects on 5-year outcomeT K Larsen, I Melle, B Auestad, et al.
Acta Psychiatrica Scandinavica|December 18, 2007
Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional studyP A Ringen, I Melle, A B Birkenaes, et al.
Oncogene|January 29, 2014
Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesisK U Sales, S Friis, J E Konkel, et al.
Acta Psychiatrica Scandinavica|August 21, 2010
Early identification of non-remission in first-episode psychosis in a two-year outcome studyErik Simonsen, S Friis, S Opjordsmoen, et al.
European Journal of Gastroenterology & Hepatology|April 16, 2002
Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1)Jeroen D van Bergeijk, J H Paul Wilson, Ole Haage Nielsen, et al.
Pageof 16